Context Therapeutics Inc.
CNTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001842952
No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Context Therapeutics Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- −3 vs. Q4 2021
- Shares held
- 2.90M
- −644.9K (−18.2%) vs. Q4 2021
- Total value
- $6.30M
- −$3.14M (−33.2%) vs. Q4 2021
- New holders
- 4
- 5 more added
- Sold out
- 7
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 79 | $34.8M |
| Q1 2026 | 60 | $194.6M |
| Q4 2025 | 43 | $96.0M |
| Q3 2025 | 37 | $66.8M |
| Q2 2025 | 39 | $45.0M |
| Q1 2025 | 42 | $43.7M |
| Q4 2024 | 52 | $76.4M |
| Q3 2024 | 42 | $111.2M |
| Q2 2024 | 34 | $114.3M |
| Q1 2024 | 25 | $5.43M |
| Q4 2023 | 24 | $4.02M |
| Q3 2023 | 23 | $3.89M |
| Q2 2023 | 22 | $3.58M |
| Q1 2023 | 22 | $722.6K |
| Q4 2022 | 24 | $2.55M |
| Q3 2022 | 24 | $4.59M |
| Q2 2022 | 20 | $6.32M |
| Q1 2022 | 16 | $6.30M |
| Q4 2021 | 19 | $9.44M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 1,165,100 | $2.53M | 1.08% | −65,730−5.3% | Reduced |
| Affinity Asset Advisors, LLC | 777,610 | $1.69M | 0.67% | +777,610 | New |
| Worth Venture Partners, LLC | 317,729 | $689.0K | 0.32% | +142,762+81.6% | Added |
| Vanguard Group Inc | 236,279 | $513.0K | 0.00% | +21,600+10.1% | Added |
| Knoll Capital Management, LLC | 139,520 | $303.0K | 0.19% | +139,520 | New |
| Veritable, L.P. | 110,249 | $239.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 49,912 | $108.0K | 0.00% | +49,912 | New |
| swisspartners Ltd. | 42,235 | $92.0K | 0.07% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 20,309 | $44.0K | 0.00% | −44,309−68.6% | Reduced |
| Citadel Advisors LLC | 18,516 | $40.0K | 0.00% | +18,516 | New |
| BlackRock Inc. | 16,961 | $37.0K | 0.00% | +5,414+46.9% | Added |
| Morgan Stanley | 10,000 | $22.0K | 0.00% | +5,000+100.0% | Added |
| Tower Research Capital LLC (TRC) | 33 | $0 | 0.00% | −2,021−98.4% | Reduced |
| Wells Fargo & Company | 64 | $0 | 0.00% | +31+93.9% | Added |
| Royal Bank of Canada | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Retirement Group, LLC | 155 | $0 | 0.00% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −762,721−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −493,531−100.0% | Sold out |
| Empery Asset Management, LP | 0 | $0 | 0.00% | −358,617−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −53,521−100.0% | Sold out |
| QCM Cayman, Ltd. | 0 | $0 | 0.00% | −14,041−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,160−100.0% | Sold out |
| Amplius Wealth Advisors, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |